ArticleSensors (Basel, Switzerland)2026
An EEG-Based Edge-AI Framework for Alzheimer's and Creutzfeldt-Jakob Disease Classification.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electroencephalography (EEG) has emerged as a promising non-invasive tool for the diagnosis of neurodegenerative disorders, and artificial intelligence (AI) has shown significant potential in this domain, as demonstrated by recent studies. However, strong inter-subject variability remains a major challenge, limiting the ability of AI-based models to learn disease-specific features that generalize across individuals, thereby hindering the development of clinically deployable subject-independent systems. In this work, we propose a cross-subject, AI-based EEG classification framework to distinguish between Alzheimer's disease (AD), Creutzfeldt-Jakob disease (CJD), and healthy control subjects using clinical EEG data collected from a local hospital. A lightweight hybrid deep learning model is developed, combining a two-layer one-dimensional convolutional neural network with a two-layer Transformer encoder to capture both local temporal patterns and long-range dependencies in EEG signals. The proposed model achieves an average classification accuracy of 97%, representing a 3% improvement over a baseline model evaluated on a cohort of 36 subjects. To assess deployment feasibility in real-time clinical settings, the trained model is implemented and evaluated on an edge-AI platform (NVIDIA Jetson AGX Orin), demonstrating energy efficiency for the inference with a compact model footprint. These results indicate that the proposed approach provides an accurate, efficient, and practically deployable solution for subject-independent EEG-based classification of neurological disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.